| Recruiting | Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer Prostatic Neoplasms, Castration-Resistant | Phase 1 | 2021-04-01 |
| Completed | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer Prostate Cancer | Phase 3 | 2018-05-29 |
| Terminated | Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy Metastatic Castration Resistant Prostate Cancer | Phase 2 | 2017-07-12 |
| Completed | An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surger Ovary Cancer | Phase 1 | 2017-01-24 |
| Completed | Phase 1 of EC1169 In Patients With Recurrent MCRPC Prostate Cancer | Phase 1 | 2014-05-01 |
| Withdrawn | Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Parti Breast Neoplasms | Phase 2 | 2014-04-01 |
| Terminated | A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) Solid Tumor | Phase 1 | 2014-02-01 |
| Completed | Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors Solid Tumors, Non Small Cell Lung Carcinoma | Phase 1 | 2013-10-01 |
| Completed | Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers Healthy | Phase 1 | 2013-04-01 |
| Terminated | A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-81 Advanced Cancer | Phase 1 | 2012-12-01 |
| Terminated | Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) Ovarian Cancer | Phase 3 | 2011-04-22 |
| Completed | Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Lin Non Small Cell Lung Cancer | Phase 2 | 2011-03-01 |
| Completed | Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) Solid Tumors | Phase 2 | 2009-12-31 |
| Completed | Study of EC0489 for the Treatment of Refractory or Metastatic Tumors Cancer | Phase 1 | 2009-04-01 |
| Completed | Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (81 Ovarian Cancer | Phase 2 | 2008-09-01 |
| Completed | Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008 Adenocarcinoma of the Lung | Phase 2 | 2007-08-01 |
| Completed | Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-0 Ovarian Cancer, Endometrial Cancer | Phase 2 | 2007-08-01 |
| Terminated | A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinom Renal Cell Carcinoma | Phase 2 | 2007-06-01 |
| Completed | Study of EC0225 for the Treatment of Refractory or Metastatic Tumors Cancer | Phase 1 | 2007-02-01 |
| Completed | Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, Cancer | Phase 1 | 2006-03-01 |
| Completed | Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Met Cancer | Phase 1 | 2005-09-01 |
| Completed | Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma | Phase 2 | 2003-11-01 |
| Completed | Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Rec Ovarian Carcinoma, Recurrent Endometrial Carcinoma | Phase 2 | 2003-08-01 |
| Completed | Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metas Recurrent or Metastatic Cancer, Head and Neck Cancer, Pancreas Cancer | Phase 2 | 2003-08-01 |
| Completed | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors Pituitary Tumors | Phase 2 | 2002-09-01 |
| Completed | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Ca Metastatic Renal Cell Carcinoma | Phase 2 | 2002-08-01 |
| Completed | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Canc Ovarian Cancer, Endometrial Cancer | Phase 1 | 2001-08-01 |
| Completed | Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients Ovarian Cancer, Healthy Volunteers | Phase 1 | 2000-08-01 |
| Completed | Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer Ovarian Cancer | N/A | 1997-12-08 |